The project aims at providing scalable solution for bioproduction of therapy based on adeno associated virus (AAV).
AAVNova is a multidisciplinary project, which is carried out in collaboration with leading actors through different areas of competence. The project will deliver a platform with a series of tools such as viral vectors, cell lines, bioproduction process and new equipment as well as improved and simplified electron microscopy support with AI-based methods for the evaluation of the AAV quality.
Project Leader of Work Package 3: Veronique Chotteau
Active from CETEG: Ye Zhang (Post-doc), Emil Sundäng (Lab engineer)
Funding: VINNOVA and industrial partners

This website is using cookiesfor statistics and a better user experience

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.